Tracking second-line Parkinson treatments over time
Part of Brain & nervous system clinical trials.
This study follows people with Parkinson’s who have troublesome “ups and downs” or involuntary movements, and who need a device/infusion treatment like deep brain stimulation, an apomorphine pump, or a Duodopa pump. It helps doctors see how these second-line treatments are working in real life and what outcomes they produce.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of Parkinson’s disease (not another similar condition).
- Your Parkinson’s symptoms include fluctuations and/or dyskinesia (unpredictable “wearing off” and/or involuntary movements).
- Your specialist believes you need one of these second-line treatments: deep brain stimulation, an apomorphine pump, or a Duodopa pump.
- You are over 21 years old.
- Your most recent MoCA memory test score is greater than 20.
- You agree to take part by signing the study consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new pump-delivered combination of Parkinson's medications (foslevodopa/foscarbidopa) in adults who have recently started having motor fluctuations but are not yet using other device therapies. It aims to see how well it works in real life and may offer better symptom control.
This study follows people with Parkinson's disease who still have movement symptoms despite taking medication. It aims to understand how the disease changes over time, which could help improve future treatments.
This study looks at a new pump treatment (foslevodopa/foscarbidopa) for people with advanced Parkinson's who are having motor fluctuations. It aims to see if it improves quality of life when started earlier in the advanced stage.
This trial tests a new treatment called DSP-1083 for people with Parkinson's disease whose symptoms are not well controlled with standard medications. The study will check if it is safe and if it helps improve movement and daily function.
This study tests a new single-dose treatment for Parkinson's disease to see if it can help reduce 'off' time—when medication wears off and symptoms return. It is for people who experience motor fluctuations and are already on a stable medication routine.
This trial tests if using a wearable sensor can help doctors better adjust Parkinson's medications to reduce motor fluctuations (times when symptoms are not well controlled). It is for people with Parkinson's who have been on levodopa for at least 4 years and experience ups and downs in their movement control.
Hear when a new Parkinson’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.